Recruiting studies: Primary Generalized Tonic Clonic Seizures

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Phase 2 · 11 location(s) · Praxis Precision Medicines · NCT06908356 A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Phase 3 · 138 location(s) · Xenon Pharmaceuticals Inc. · NCT05667142 ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
Phase 3 · 25 location(s) · Ono Pharmaceutical Co., Ltd. · NCT06579573 A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized T
Phase N/A · 1 location(s) · Eisai Co., Ltd. · NCT06657378 Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastas
Phase 2 · 1 location(s) · Ayal A. Aizer, MD · NCT07130786

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.